Autres langues Biogen Inc.

Actions

BIIB

US09062X1037

Temps réel estimé Cboe BZX Autres places de cotation 20:07:00 10/06/2024			Varia. 5j.	Varia. 1 janv.
227,8 ^USD	+1,04 %		-0,91 %	-12,00 %

13:00	Des conseillers de la FDA américaine examinent le médicament d'Eli Lilly contre la maladie d'Alzheimer	RE
09:44	Biogen et Eisai annoncent que la demande de traitement d'entretien pour la maladie d'Alzheimer a été acceptée par la FDA américaine	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

US FDA advisers to review Eli Lilly Alzheimer's drug	13:00
Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm	11:46
Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA	09:44
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease	01:38
FDA Accepts Eisai's Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease	01:31
Biogen Inc. Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP	08/06
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses to Contact the Firm	07/06
US FDA panel to vote on data, risk profile of Lilly Alzheimer's drug	06/06
Italien hat Novartis und weitere Pharmafirmen wegen Augenarznei im Visier	06/06
Italienische Wettbewerbsbehörde nimmt vier Pharmakonzerne ins Visier	06/06
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	06/06
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB	06/06
Novartis and others face Italy antitrust probe over eye drug	06/06
FINAL DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm	05/06
Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class Action - BIIB	05/06
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)	04/06
Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join - Contact Levi & Korsinsky	04/06
Robbins LLP Urges BIIB Investors With Large Losses to Contact the Firm for Information About the Biogen Inc. Class Action	04/06
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)	03/06
Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel	03/06

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Biogen Inc.

Actions

BIIB

US09062X1037

Autres langues

Filtres